Uncategorized

Damian Garde

STAT Plus: Pharmalittle: Purdue pleads guilty to opioid charges; Chinese firm files for Covid-19 vaccine approval

Damian Garde, Meg Tirrell and Adam Feuerstein

Listen: Bracing for a pandemic winter, Biogen’s fortune at the FDA, and remembering a remarkable 12-year-old

Pharmalot Ed Silverman

STAT Plus: Up and down the ladder: The latest comings and goings

Erin Brodwin

How Pinterest beat back vaccine misinformation — and what Facebook could learn from its approach

Pharma Adam Feuerstein

STAT Plus: Merck chronic cough drug shows mixed results in late-stage clinical trials, raising questions about its future

Rebecca Robbins, Casey Ross and Erin Brodwin

STAT Health Tech: Elon Musk’s secretive brain implants startup & Verily’s move into health insurance

Jonathan Chan

STAT China: Two more Hong Kong IPO filings, and Beijing’s latest drug price cuts

Nicholas Florko

STAT Plus: House Democrats are using the budget process to slam the Trump administration’s Covid-19 response  

Pharmalot Ed Silverman

STAT Plus: AbbVie may face fewer wrinkles after judge suggests a 10-year ban on a Botox rival

Matthew Herper

STAT Plus: Eli Lilly gets an edge against Pfizer in adjuvant breast cancer

Pharmalot Ed Silverman

STAT Plus: California supports an attorney’s unusual whistleblower lawsuit against ‘fraudulent’ patents

Lev Facher

6 takeaways from the Senate’s surreal virtual hearing on the U.S. coronavirus response

Shraddha Chakradhar

Last chance! Sign up for our STAT Plus event – “Gene therapy has arrived. What’s next?”

Biotech Adam Feuerstein

STAT Plus: Karyopharm to seek expanded use of multiple myeloma drug following positive clinical trial

Damian Garde, Rebecca Robbins and Adam Feuerstein

Listen: Drug industry infighting, the human side of genetic medicine, and a big year for the microbiome

Pharma Jonathan Saltzman — Boston Globe

STAT Plus: Insys founder gets 5½ years in jail for his role in fentanyl prescription scheme

STAT

STAT Plus: [email protected] 2020

Biotech Matthew Herper

STAT Plus: Cleveland Clinic’s Nissen denies any communication with FDA about Amarin’s Vascepa

Politics Lev Facher

STAT Plus: Insurance, pharma figures spar over drug price legislation’s innovation impact

Biotech Jonathan Saltzman — Boston Globe

STAT Plus: New MS drug from Biogen and Alkermes wins approval

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Four drug companies settle Ohio opioid suit; J&J recalls baby powder due to asbestos

Shraddha Chakradhar

STAT Plus: Our fourth quarter biotech scorecard

Health Helen Branswell

An updated guide to the changing science of flu shots

Biotech Jonathan Saltzman — Boston Globe

STAT Plus: UCB’s $2.5 billion purchase of Ra Pharma underscores immunology focus

Business Matthew Herper

STAT Plus: Illumina confronts the innovator’s dilemma

Health Matt Stout — Boston Globe

Mass. declares public health emergency, orders 4-month ban on all vaping products

Biotech Damian Garde

STAT Plus: A biotech startup hopes to disarm cancer by targeting a genetic bandolier

Biotech Isabella Tran — Boston Globe

STAT Plus: Biotech industry aims to spark girls’ interests in science long before high school

Biotech Damian Garde

STAT Plus: Myovant’s uterine fibroid drug meets goals in trial, setting up competition with AbbVie